Abstract
Dysregulation of lipid homeostasis is intimately associated with defects in insulin secretion, a key feature of type 2 diabetes. Here, we explore the role of the putative lipid transporter ABCA12 in regulating insulin secretion from β-cells. Mice with β-cell-specific deletion of Abca12 display impaired glucose-stimulated insulin secretion and eventual islet inflammation and β-cell death. ABCA12's action in the pancreas is independent of changes in the abundance of two other cholesterol transporters, ABCA1 and ABCG1, or of changes in cellular cholesterol or ceramide content. Instead, loss of ABCA12 results in defects in the genesis and fusion of insulin secretory granules and increases in the abundance of lipid rafts at the cell membrane. These changes are associated with dysregulation of the small GTPase CDC42 and with decreased actin polymerisation. Our findings establish a new, pleiotropic role for ABCA12 in regulating pancreatic lipid homeostasis and insulin secretion.
| Original language | English |
|---|---|
| Article number | e48692 |
| Number of pages | 19 |
| Journal | EMBO Reports |
| Volume | 21 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 4 Mar 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ABCA12
- cholesterol homeostasis
- insulin secretion
- lipid rafts
- type 2 diabetes
Projects
- 4 Finished
-
Modulating inflammation as a therapy for Harlequin Ichthyosis
Smyth, I. (Primary Chief Investigator (PCI)), Cottle, D. (Chief Investigator (CI)), Nold, M. (Chief Investigator (CI)) & Nold, C. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/17 → 31/12/20
Project: Research
-
NHMRC Research Fellowship
Smyth, I. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/16 → 31/12/20
Project: Research
-
CVDP: A Program of Translational CVD Medicine: Identifying new targets for prevention and treatment
Kaye, D. (Primary Chief Investigator (PCI)), Jennings, G. (Chief Investigator (CI)), Esler, M. (Chief Investigator (CI)), Dart, A. M. (Chief Investigator (CI)), Kingwell, B. (Chief Investigator (CI)), Chin-Dusting, J. (Chief Investigator (CI)) & Sviridov, D. (Chief Investigator (CI))
1/01/13 → 31/12/17
Project: Research
Equipment
-
FlowCore (FLOW)
Fryga, A. (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility
-
Monash Animal Research Platform (MARP)
Findlay, C. (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility
-
Monash Histology Platform (MHP)
Cohen, C. (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver